- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Joe Mclane, Merck
I joined Merck in 1996 as a customer account representative, processing pharmaceutical and vaccine orders for our direct customers.
Joe McLane
Senior Manager, Global Marketing Communications, HPV Franchise, Merck
I joined Merck in 1996 as a customer account representative, processing pharmaceutical and vaccine orders for our direct customers. I wanted to have a career in pharma, and. more importantly, at Merck, because I wanted to be part of something bigger and make a difference. My major accomplishments so far include "Tell Someone," a disease campaign that educated women on the link between cervical cancer and human papillomavirus, and the launch of "One Less," our branded campaign that announced the availability of [HPV vaccine] Gardasil.
Social networks are the new frontier for pharma. Social networks, word-of-mouth initiatives, and other social media will help stimulate conversations. Consumers trust healthcare information they learn in social circles; we are now exploring how to work with these unique networks to further our messages.
In 10 years, I hope to be doing what I love to do with people who are as passionate as I am. I'm trying to convince myself that 40 is the new 30.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.
